| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.88B | 7.90B | 8.20B | 8.64B | 8.34B |
| Gross Profit | 1.40B | 1.53B | 1.65B | 1.94B | 2.39B |
| EBITDA | 319.13M | 675.54M | 826.15M | -393.09M | 1.50B |
| Net Income | 103.30M | -272.36M | 273.25M | -927.12M | 1.11B |
Balance Sheet | |||||
| Total Assets | 12.95B | 12.99B | 14.24B | 14.60B | 18.16B |
| Cash, Cash Equivalents and Short-Term Investments | 3.21B | 3.94B | 4.83B | 4.76B | 9.84B |
| Total Debt | 29.30M | 43.77M | 368.28M | 615.17M | 3.24B |
| Total Liabilities | 4.98B | 4.95B | 5.59B | 6.23B | 8.93B |
| Stockholders Equity | 7.75B | 7.66B | 7.92B | 7.57B | 8.53B |
Cash Flow | |||||
| Free Cash Flow | 764.36M | -108.32M | 786.86M | -1.75B | 1.09B |
| Operating Cash Flow | 1.07B | 201.37M | 1.03B | -1.51B | 1.21B |
| Investing Cash Flow | -1.65B | -1.34B | 921.38M | -2.93B | -1.24B |
| Financing Cash Flow | -27.14M | -478.58M | -470.81M | -3.09B | 4.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$4.07B | 9.33 | 18.82% | 5.77% | 17.65% | 9.64% | |
75 Outperform | HK$16.77B | 10.46 | 15.06% | 4.43% | 4.91% | 4.61% | |
73 Outperform | HK$3.99B | 11.85 | 11.54% | 12.09% | -9.21% | -47.87% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | HK$1.33B | 13.25 | -5.89% | ― | -0.10% | ― | |
59 Neutral | HK$3.45B | 27.68 | -12.90% | 4.41% | -7.01% | ― | |
57 Neutral | HK$19.77B | 30.19 | 1.68% | 4.94% | 9.98% | -68.38% |